Corteva Inc
Q4 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: −1.15%.
Did CTVA Beat Earnings? Q4 2025 Results
Corteva closed out Q4 2025 with a mixed earnings picture, narrowly beating profit expectations while falling short on revenue. The agricultural sciences company posted non-GAAP operating EPS of $0.22, edging past the $0.22 consensus estimate by 1.76%, but quarterly net sales of $3.91 billion trailed the $4.23 billion consensus by 7.49% and slipped 1.7% year-over-year, as seasonal timing shifts pushed volumes into adjacent quarters across both its Seed and Crop Protection segments. Beneath the headline numbers, a $610 million charge tied to a landmark litigation resolution with Bayer weighed heavily on GAAP results, producing a loss from continuing operations of $537 million. Yet that same settlement carries significant strategic value, accelerating Corteva's path to royalty neutrality by two years and potentially unlocking roughly $1 billion in cumulative earnings over the next decade. Looking ahead, management guided for 2026 operating EPS of $3.45 to $3.70 and operating EBITDA of $4 billion to $4.2 billion, even as a planned separation into two independent companies by late 2026 introduces execution risks that have already drawn some analyst scrutiny.
- Demand for latest Seed technology and price-for-value strategy execution
- Volume growth in new Crop Protection products and biologicals
- Productivity savings and raw material deflation across segments
- Increased corn area and share gains in North America and Brazil
- Reduction of net royalty expense in Seed
- Efficient working capital management driving robust cash generation
“Our delivery of strong second-half and full-year results reflects continued demand for our differentiated technologies and disciplined execution across the company. In Seed, performance was driven by our latest technology, growth in licensing and sustained productivity improvements. In Crop Protection, despite an ongoing challenging pricing environment in key regions including Latin America and Asia Pacific, we delivered sales and earnings growth, driven by volume gains in new products and biologicals and meaningful cost reductions. We also progressed actions related to our planned separation, and we are on track to complete the separation in the second half of 2026. We look ahead to 2026 with optimism – our products, our employees' focus on execution, and our accelerated freedom to operate across many crops promises to deliver yet another year of growth, productivity and value creation for both farmers and shareholders.”
Corteva CEO, on the earnings call
Forward Guidance & Outlook
For full-year 2026, Corteva expects Operating EBITDA of $4.0 billion to $4.2 billion, representing approximately 7% growth at the midpoint. Operating EPS is expected to be $3.45 to $3.70 per share, also reflecting approximately 7% growth at the midpoint. The guidance incorporates an estimated ~$80 million incremental tariff impact across both businesses. The global agriculture outlook remains mixed with strong crop demand and production but pressured commodity prices and farmer margins. The global crop protection industry is expected to improve modestly with volume gains more than offsetting ongoing pricing pressure in certain key regions including Latin America and Asia Pacific. Any shift from corn to soybean planted acres in the US in 2026 is expected to be manageable.
CTVA YoY Financials
CTVA Revenue by Segment
CTVA Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.